Finance

Beta
Lists
AYTU:NASDAQ
Aytu Biopharma Inc
$2.30
+0.44%
(+0.0100) 1D
Jun 9, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AYTU...
Open
$2.25
High
$2.35
Low
$2.24
Mkt. cap
24.69M
Avg. vol.
48.85K
Volume
35.48K
52-wk high
$3.06
52-wk low
$1.65
EPS
-$4.41
Beta
0.24
Shares outstanding
10.73M
No. of employees
83
Open
$2.25
High
$2.35
Low
$2.24
Mkt. cap
24.69M
Avg. vol.
48.85K
Volume
35.48K
52-wk high
$3.06
52-wk low
$1.65
EPS
-$4.41
Beta
0.24
Shares outstanding
10.73M
No. of employees
83
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to AYTU in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AYTU in the last 3 months.
Highest
Current $2.30
$14.00 (+508.70%)
Average
$9.33 (+305.65%)
Lowest
$7.00 (+204.35%)
News stories
From sources across the web
About Aytu Biopharma Inc
CEO-
Employees83
Founded2002
HeadquartersDenver, Colorado, United States
SectorPharmaceutical industry
Websiteaytubio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.14M
13.89M
15.16M
12.41M
Cost of goods sold
4.88M
4.70M
5.54M
4.81M
Cost of revenue
4.88M
4.70M
5.54M
4.81M
Research and development expenses
216.00K
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.48M
10.25M
11.07M
10.90M
Operating expense
9.61M
10.69M
11.59M
11.66M
Total operating expenses
14.50M
15.39M
17.14M
16.48M
Operating income
640.00K
-1.50M
-1.97M
-4.06M
Other non operating income
-11.09M
3.98M
-8.05M
-1.11M
EBT including unusual items
-19.44M
1.96M
-10.58M
-5.61M
EBT excluding unusual items
-11.18M
1.96M
-10.58M
-5.61M
Income tax expense
437.00K
-
-
10.00K
Effective tax rate
-2.25%
-
-
-0.18%
Other operating expenses
-
-
-
-
Net income
-19.82M
1.96M
-10.58M
-5.62M
Net profit margin
-130.94%
14.15%
-69.79%
-45.27%
Earnings per share
-0.08
-0.09
-0.23
-0.41
Interest and investment income
-
-
-
-
Interest expense
-730.00K
-516.00K
-560.00K
-436.00K
Net interest expenses
-730.00K
-516.00K
-560.00K
-436.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
1.93M
-701.00K
-1.08M
-2.94M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer